UK approves oral pill to treat advanced prostate cancer
HQ Team July 19, 2024: A new pill that treats hormone sensitive advance prostate cancer has been approved by the National Institute for.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team July 19, 2024: A new pill that treats hormone sensitive advance prostate cancer has been approved by the National Institute for.
HQ Team July 18, 2024: A United Kingdom study found that Over-the-counter (OTC) nasal sprays can reduce the symptoms and duration of respiratory.
Conduct disorder is a result of extensive changes in the structure of the brain and is most noticeable in the cerebral cortex, or.
Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.
British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.
Climate change is making days longer by a few milliseconds as the ice melts in Antarctica and Greenland is causing a shift in.
Novo Nordisk, has been denied approval for its type 1 diabetic medicine by the USFDA, according to the Danish drugmaker.
OraSure Technologies’ hepatitis C virus self-test has been prequalified by the World Health Organization in a global bid to eliminate the disease.
Pharmacy benefit managers, who handle about 95% of US prescriptions, are inflating drug costs and squeezing independent pharmacies, according to a report.
Intensive diet and lifestyle changes may forestall a cognitive decline in Alzheimer’s disease and make progress for patients during early stages, a study.